Get started
Author

L. R. Zacharski

Decreased Cancer Risk After Iron Reduction in Patients With Peripheral Arterial Disease: Results From a Randomized Trial
2008 · L. R. Zacharski, B. K. Chow, et al. · JNCI Journal of the National Cancer Institute · 304
Transformation and motility of human platelets: details of the shape change and release reaction observed by optical and electron microscopy.
1979 · R D Allen, L R Zacharski, et al. · The Journal of Cell Biology · 205
Tumor Cell Procoagulant and Urokinase Expression in Carcinoma of the Ovary
1993 · L. R. Zacharski, V. A. Memoli, et al. · JNCI Journal of the National Cancer Institute · 59
Antimetastatic Agents. I. Role of Cellular Procoagulants in the Pathogenesis of Fibrin Deposition in Cancer and the Use of Anticoagulants and/or Antiplatelet Drugs in Cancer Treatment
1988 · Frederick Rickles, Wayne Hancock, et al. · Seminars in Thrombosis and Hemostasis · 55
Coagulation-cancer interaction in situ in renal cell carcinoma
1986 · LR Zacharski, VA Memoli, et al. · Blood · 53
Malignant Melanoma: Interaction with Coagulation and Fibrinolysis Pathways In Situ
1990 · Marek Z. Wojtukiewicz, Leo R. Zacharski, et al. · American Journal of Clinical Pathology · 50
Fibrinogen-fibrin transformation in situ in renal cell carcinoma.
1990 · M Z Wojtukiewicz, L R Zacharski, et al. · PubMed · 47
Effect of perioperative low-dose heparin administration on the course of colon cancer.
1983 · F H Kohanna, J Sweeney, et al. · PubMed · 37
Hereditary haemochromatosis and the hypothesis that iron depletion protects against ischemic heart disease
2001 · J. L. Sullivan, L. R. Zacharski · European Journal of Clinical Investigation · 29
Low molecular weight heparin treatment for malignant melanoma: a pilot clinical trial
2003 · L. Kozlowski, K. Ostrowska, et al. · Thrombosis and Haemostasis · 26
Reduction of salivary tissue factor (thromboplastin) activity by warfarin therapy
1979 · LR Zacharski, R Rosenstein · Blood · 26
PDF
Bleeding complications from warfarin anticoagulation in patients with malignancy.
1985 · L R Zacharski, W G Henderson, et al. · PubMed · 19
Postoperative elevation of human peripheral blood monocyte tissue factor coagulant activity.
1986 · S A Blakowski, L R Zacharski, et al. · PubMed · 15
Blood Coagulation Activation in Cancer: Challenges for Cancer Treatment
1995 · V. Costantini, L. R. Zacharski · Hämostaseologie · 14
Hypercoagulability preceding cancer
2005 · L.R. ZACHARSKI · Journal of Thrombosis and Haemostasis · 11
Urokinase inhibits HL-60 cell proliferation in vitro.
1994 · A L Howell, J A Hunt, et al. · PubMed · 10
The coagulation system as a target for experimental therapy of human gliomas
2003 · JT Loynes, LR Zacharski · Expert Opinion on Therapeutic Targets · 9
Coagulation biology in glioma pathogenesis: a missing link?
2005 · C.E. FADUL, L.R. ZACHARSKI · Journal of Thrombosis and Haemostasis · 8
PDF
The biologic basis for anticoagulant treatment of cancer.
1982 · L R Zacharski · PubMed · 8
Hemochromatosis, iron toxicity and disease
2010 · L. R. Zacharski · Journal of Internal Medicine · 6
PDF
Rationale for treatment of cancer with calcium antagonists. A review.
1988 · L R Zacharski · PubMed · 6
Studies of possible mechanisms for the effect of urokinase therapy in small cell carcinoma of the lung
1995 · K. R. Meehan, L. R. Zacharski, et al. · Blood Coagulation & Fibrinolysis · 4
Effect of polyribonucleotides on in vitro platelet aggregation induced by acid-soluble collagen and other aggregating agents
1977 · R Rosenstein, LR Zacharski, et al. · Blood · 4
A Clinical Trial of Nafazatrom (Bay g 6575) in Advanced Cancer
1986 · J. F. OʼDonnell, S. A. Blakowski, et al. · American Journal of Clinical Oncology · 3
Rationale for heparin treatment of colon cancer
2000 · D. L. Ornstein, L. R. Zacharski · Hämostaseologie · 2
Works count: 34
Citation count: 1,016
H-index: 14
I10-index: 16
Year
Topic
Type